-
Posted by
Two Blokes Mon at 10:45 AM -
Filed in
Stock
-
1 view
Sarepta Therapeutics traded lower on Monday, extending a slide as the company took the unusual step of refusing a Food and Drug Administration request to stop selling a drug tied to three deaths.